Libtayo - direct healthcare professional communication (DHPC)

cemiplimab
DHPCHuman

Finnish is available via eTranslation, the European Commission's machine translation service.

Translate to Finnish | Important information about machine translation

Tietoja

This direct healthcare professional communication (DHPC) contains important information for healthcare professionals prescribing, dispensing or administering the medicine(s). It also includes a communication plan with details of intended recipients and the dissemination date.

Asiakirjat

Direct healthcare professional communication (DHPC) : Libtayo (cemiplimab) 350 mg concentrate for solution for infusion: Batch / lot number and expiry date may become illegible following sanitisation and wiping of vial label

English (EN) (187.46 KB - PDF)

Julkaistu ensimmäisen kerran:
Näytä

Key facts

Medicine name
Libtayo
Active substance
cemiplimab
Therapeutic area (MeSH)
Carcinoma, Squamous Cell
DHPC type
Quality defect
Human ATC codes
L01XC33
Dissemination date

Share this page